Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry
In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division
FDA carries Action On Two Cancer Drugs Over To 1996
NRC Reports Says NIH Security Of nuclear Materials a Problem
Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?
AACR, Kellogg’s Co. Sponsor Award
Trending Stories
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities